(Corrects title and first paragraph to reflect that CDC accelerated the release of doses, not released doses)
The U.S. Centers for Disease Control and Prevention (CDC) announced Thursday that it has accelerated the availability of more than 77,000 additional doses of Sanofi SASY.PA and AstraZeneca AZN.L respiratory syncytial virus drug Beyfortus (RSV) ().